EP3355884
Tetrahýdró-1H-pýrídó[3,4-b]indól and-estrógenlyf
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.9.2016EP published:
28.4.2021EP application number:
16852640.8
EP translation filed:
21.7.2021Grant published:
15.9.2021EPO information:
European Patent Register
Max expiry date:
28.9.2036Expiry date:
28.9.2026Next due date:
30.9.2026
Title:
TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS
Timeline
Today
29.9.2016EP application
28.4.2021EP Publication
21.7.2021Translation submitted
15.9.2021Registration published
28.9.2026Expires
Owner
Name:
Olema Pharmaceuticals, Inc.Address:
665 Third Street, Suite 250, San Francisco, CA 94107, US
Inventor
Name:
MYLES, David, C.Address:
Berkeley, CA 94705, US
Name:
KUSHNER, Peter, J.Address:
San Francisco, CA 94122, US
Name:
HARMON, Cyrus, L.Address:
Bolinas, CA 94924, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562235900 PDate:
1.10.2015Country:
US
Classification
Categories:
C07D 471/04, C07D 471/02, A61K 31/437, A61K 31/506, A61K 31/4545
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 31.8.2021
Expires: 28.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 20.9.2022
Expires: 28.9.2023
Payer: Patice ehf.
Number: 8
Paid: 19.9.2023
Expires: 28.9.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 17.9.2024
Expires: 28.9.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.9.2025
Expires: 28.9.2026
Payer: Árnason Faktor ehf.